Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 43

  1. Cat.No. Product Name Information/Activity
  2. BCC7308 PMPA (NMDA antagonist) 113919-36-1 PMPA (NMDA antagonist) chemical structure
  3. BCC5918 PPDA 684283-16-7 PPDA chemical structure
  4. BCC7309 PPPA 113190-92-4 PPPA chemical structure
  5. BCC6292 QNZ 46 QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively). QNZ 46 chemical structure
  6. BCC7129 Remacemide hydrochloride 111686-79-4 Remacemide hydrochloride chemical structure
  7. BCC7234 Ro 04-5595 hydrochloride 64047-73-0 Ro 04-5595 hydrochloride chemical structure
  8. BCC4159 Ro 25-6981 Maleate Ro 25-6981 Maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit. Ro 25-6981 Maleate chemical structure
  9. BCC7619 Ro 61-8048 Ro 61-8048 is a potent and selective inhibitors of kynurenine hydroxylase with IC50 of 37 nM. Ro 61-8048 chemical structure
  10. BCC7655 Ro 8-4304 hydrochloride 1312991-77-7 Ro 8-4304 hydrochloride chemical structure
  11. BCC6992 SDZ 220-040 174575-40-7 SDZ 220-040 chemical structure

Items 421 to 430 of 509 total